What Are Hypomethylating Agents?

HealthTree University: Know Your Therapy - Hypomethylating Agents (Azacitidine and Decitabine)

Hypomethylating agents are a type of medication used to treat acute myeloid leukemia (AML) by reducing the amount of methylation in cells. These drugs can help slow the growth of cancer cells and promote the growth of healthy bone marrow cells. If you want to learn more about hypomethylating agents for AML, check out the videos below! You can watch the full course on HealthTree University for free. Create a HealthTree University account to track your progress, take notes, and bookmark favorite lessons.

18.01    What are hypomethylating agents?

18.02    How do hypomethylating agents work to treat AML?

18.03    What are the hypomethylating agents currently being used to treat AML? How are they administered?

We’d like to thank our faculty who donated their time in creating these videos, including:

• Elias Jabbour, MD

Want more?

We have over 100 HealthTree University videos online at HealthTree University! Learn the basics (and the not-so-basics) of AML from some of the top AML doctors in the world!

• AML Basics Part 1
• AML Basics Part 2
• AML Basics Part 3
• AML Genetics
• Building Your Healthcare Team
• AML Drug Classes
• Starting AML Treatment
• Allogeneic Stem Cell Transplant for AML
• Myelodysplastic Syndrome (MDS)
• Relapsed and Refractory AML
• AML Clinical Trials
• AML in Women
• An Introduction to Childhood AML
• AML Financial Toxicity
• Geriatric Care and AML
• Palliative Care